A hallmark of systemic lupus erythematosus is high titers of circulating autoantibody. A novel CD11c + B cell subset has been identified that is critical for the development of autoimmunity. However, the role of CD11c 
Introduction
Systemic lupus erythematosus (SLE) is a prototypic autoimmune disease characterized by an array of autoantibody that targets multiple normal cellular components [1] [2] [3] . When encountered with self-antigens, autoantibody can bind with them to form immunoglobulin complexes (ICs), which deposit in the kidney, activate complement system, and appear a series of inflammatory responses. Accumulating evidence has indicated that the presence of certain autoantibody is highly associated with some symptoms of the disease [4, 5] . For example, antiphospholipid antibodies are critically linked to the development of thrombotic events and obstetric morbidity [6] , anti-RNP antibodies are associated with myositis and Raynaud's phenomenon [7] , and anti-dsDNA antibodies are associated with lupus nephritis [8] . However, the characterization of B cell that producing the distinct kinds of pathogenic antibodies is still unclear.
Chromatin, the native complex of histones and DNA found in the cell nucleus of eukaryotes, consists of approximately 40% DNA, 40% histones, and 20% non-histone proteins, RNA and other macromolecules [9] .
Data accumulated in recent years, have indicated that anti-chromatin autoantibody were involved in the pathogenesis of SLE and associated with disease activity and lupus nephritis [10] [11] [12] . For example, immunization with active chromatin induced lupus-like syndrome in BALB/c mice [13] . Several studies of lupus-like murine models have found genetic loci, such as sle1, that are related to anti-chromatin antibodies production [14] . In certain knock-out mice (for C1q, serumamyloid P [SAP] and Dnase I), impaired phagocytosis of apoptotic material may result in an autoimmune response to chromatin and glomerulonephritis [15, 16] . However, it is not quite clear how B cells lose itself tolerance to chromatin in the development of lupus.
Transfer of MHC II-mismatched splenocytes from Bm12 mice into B6 mice causes a chronic graft versus host disease (cGVHD), which is characterized by the production of high titers of autoantibody and immunopathology that closely resemble SLE [17] [18] [19] . The majority of autoantibody in cGVHD are anti-chromatin and anti-erythrocytes [20] . Recently, a novel B cell subset-CD19 + CD11c + cell is identified in aged female B6 mice, which is able to produce large amounts of anti-chromatin autoantibody in response to TLR7 ligand in vitro [21] . However, little is known about the differentiation and function of CD19 + CD11c + cells in the development of lupus.
In this study, we present data identifying T-bet as an essential factor in regulating the development of 
cGVHD induction
Single-cell suspension of Bm12 splenocytes was prepared in 1 x PBS, filtered through 0.2 μ m sterile nylon mesh. 5 x 10^7 splenocytes was then i.p. injected into B6 mice. After two weeks, the recipient mice were sacrificed for analysis.
Abs and Flow cytometry
The following mAbs used for staining were purchased from BioLegend: Bv421 anti-CD4, PerCP anti-CD8a, APC anti-CD69, PE-Cy7 anti-CXCR5, PE anti-PD-1, AF-700 anti-CD44, FITC anti-CD62L, APC-Cy7
anti-CD19, PerCP-Cy5.5 anti-CD19, PE anti-FasR, FITC anti-GL7, BV421 anti-CD138, PE anti-CD138, PE-Cy7 anti-CD11b, APC-eF780 anti-CD11c, APC anti-IFNγ, and APC anti-T-bet.eF506 Live/Dead dye was obtained from eBioscience. Human Antibodies were bought from BD bioscience: Bv605 anti-CD19, FITC anti-CD11c. Cells were fixed in BD Cytofix™ buffer (BD bioscience) before FACS analysis.
Intracellular staining for T-bet was performed by using BD Cytofix/Cytoperm™ Kit (BD bioscience). Data were collected on Fortessa2 and LSR-II flow cytometer and analyzed by FlowJo software.
Cell isolation and in vitro culture
Spleen cells from Bm12→B6 cGVHD mice were pooled together (n=5). 
ELISA for anti-chromatin Abs
Chromatin was prepared as previously described [25, 26] . Plates were coated with chromatin at 3 ug/ml overnight at 4 °C. The plates were then washed and incubated with blocking buffer for 2 h at Room
Temperature (RT). The plates were washed again, and then 1/500 diluted Serum samples were added in duplicate and incubated for 2h at RT. Biotin-labeled anti-IgG, anti-IgG1, anti-IgG2a, anti-IgG2b, and IgG3
(BioLegend) were used as capture antibodies. And Streptavidin-conjugated HRP (Thermo Scientific) was used as detective antibody. 1 x TMB (eBioscience) was then added and incubated for 30 min at RT. 2 N sulfuric acid was used as stop solution. O.D values were then measured at 450 nm and 570 nm.
Depletion of CD11c + B cell in cGVHD mice
CD11c-DTR mice with cGVHD were induced by transferring 5 x 10 7 splenocytes from Bm12. For depletion of CD11c + cells, mice were then intraperitoneally injected with 100 ng Diphtheria toxin in 200 uL PBS (Sigma) at day 7, day 9 and day 11-post cGVHD induction. The efficiency of depletion was then examined by flow cytometry14 day post cGVHD induction.
Statistical analysis
Data were analyzed using GraphPad Prism (version 5.01). Statistical differences were calculated using one-way ANOVA and the Student t test. Nonparametric correlation (spearman) was used for correlation studies. Values are presented as the mean ± SD. A value of p<0.05 was considered to be statistically significant.
Results

CD11c + B cells were increased in cGVHD autoimmune mice
Consistent with a previous study [20] , we found that B6 mice transferred with splenocytes from Bm12 mice after 14 days developed a syndrome which closely resembles systemic lupus erythematosus. As illustrated in Figure 1A and B, both mass and cell number of spleens in the cGVHD group was elevated along with higher levels of anti-chromatin IgG and IgG2a antibodies in sera compared with B6 to B6 mice at 14 days after cGVHD induction. It is reported that CD11c + B cell population accumulated in both old female mice and human with autoimmune disease, and might play a direct role in the development of autoimmunity [21] . Our data showed that CD11c + B cells were dramatically increased in the development of cGVHD ( Figure 1C ). The effector mechanisms of subclasses of antibodies were distinct due to different constant regions. IgG2a is reported to have the most protective and pathogenic properties among mouse IgG subclasses [27, 28] .
Notably, we found that anti-chromatin IgG2a was exclusively produced by CD11c + CD138 + plasma cells ( Figure 2C ). 
Depletion of CD11c
T-bet + CD11c + B cells were significantly increased after cGVHD induction
IgG2a is known as the greatest pathogenic antibody in autoimmune disease [29, 30] . Many studies have demonstrated that T-bet is critical for IgG2a class switching [31, 32] and IgG2a memory response [33] .
Recently, it is reported that T-bet drives CD11c + B cells activation to secrete virus-specific IgG2a antibody upon virus infection [34] . Thus, we next investigated the role of T-bet in CD11c + B cell differentiation and anti-chromatin IgG2a production in cGVHD-induced lupus. As shown by qPCR, T-bet expression was remarkably upregulated in spleen B cell of mice obtained splenocytes from Bm12at 14 days. However, no significant change in non B cell between Bm12 to B6 and B6 to B6 ( Figure 4A) . Furthermore, the mice that received Bm12 splenocytes showed more T-bet + CD11c + CD19 + B cells than those received B6 splenocytes ( Figure 4B ). Meanwhile, CD138 + plasma cells were dramatically expanded in cGVHD mice. And surprisingly, above 70% of CD138 + cells were IgG2a positive (Supplementary Figure 1B) . Interestingly, the fraction of T-bet + CD11c + was significantly increased in CD138 + plasma cells (Supplementary Figure 1C) .
Therefore, these results suggested that T-bet expression may contribute to the production of anti-chromatin
IgG2a antibodies in the development of cGVHD.
Depletion of T-bet + B cells ameliorated anti-chromatin IgG2a production in vivo
Next, we wondered whether depletion of T-bet + CD11c + CD19 + B cells in cGVHD-induced mice could reduce the level of anti-chromatin IgG in vivo. We generated B cell specific T-bet-/-mice by transplanting 20% T-bet-deficient B bone marrow with 80% μ MT bone marrow into irradiated μ MT mice and then induced the cGVHD model ( Figure 4C ). As expected, depletion of T-bet + B cells inhibited the expression of CD11c in B cell after cGVHD induction ( Figure 4D) . Moreover, the level of anti-chromatin IgG and IgG2a was significantly decreased in the absence of T-bet + B cells, yet no changes of anti-chromatin IgG1 production ( Figure 4E ). Taken together, our data demonstrated that T-bet is critical for CD11c + B cells differentiation and anti-chromatin IgG2a production in cGVHD-induced lupus.
T-bet + CD11c + CD19 + B cells were significantly increased in lupus patients
Next, we investigated the abnormality of T-bet + CD11c + CD19 + B cells in lupus patients. As shown in Figure   5A , the frequency of T-bet + CD11c + CD19 + B cells was significantly increased in PBMC of lupus patients.
We then analyzed the relationship between the frequency of T- Figure   3A and B). However, the proportion of T-bet + CD11c + CD19 + B cells positively correlated with the serum titer of anti-chromatin IgG antibodies in SLE patients (P = 0.0226, Spearman's r = 0.5335; Figure 5B ).
Moreover, we found that the percentage of T-bet + CD11c + CD19 + B cells was relatively higher in patients with nephritis than in those without nephritis ( Figure 5C ). Then we also analyzed the relationship between the percentage of T-bet + CD11c + CD19 + B cells and disease activity in the same group of SLE patients.
Percentage of T-bet + CD11c + CD19 + B cells was higher in patients with moderate or severe disease than in those with inactive disease ( Figure 5D ). Our data indicated that T-bet + CD11c + CD19 + B cells might be responsible for the abnormal levels of anti-chromatin in SLE patients, which might be helpful in the diagnosis and treatment of SLE.
Discussion:
In this manuscript, we characterized an unexpected-CD11c Early studies show that T-bet expression in the B lineage promotes class switching to IgG2a [32] and is indispensable for IgG2a memory formation [35] . Recently, Rubtsova et al revealed that T-bet + CD11c + B cells appear at the peak of antiviral response secrete antiviral IgG2a and essential for effective viral clearance [34] . IgG2a is the most potent isotype in mediating the development of lupus [36] [37] [38] . In our study, we found that CD138 + plasma cells were markedly increased at 14 day in cGVHD mice. And interestingly, above 70% of CD138 + cells were IgG2a positive. Moreover, T-bet + CD11c + CD138 + cells were significantly increased. The evidence suggests that the expression of T-bet and CD11c might be induced in a small population of B cell in the development of lupus, which might be involved in IgG2a + plasma cell differentiation. However, the molecular regulatory mechanism of T-bet needs to be further explored.
IFNγ was reported to play a pathogenic role in lupus nephritis. Depletion of IFNγ significantly improved renal disease induced by Pristane, with reduction of the production of anti-DNA/chromatin autoantibody [39] [40] [41] . Treatment of MRL-Lpr mice with IFNγR/Fc significantly reduced serum levels of IFNγ and autoantibody, consequently improving renal pathology. IFNγ is well known to be able to induce B cell
IgG2a class-switching [42] . In vitro study showed that IFNγ and anti-IgM synergistically induced T-bet expression in B cell in a STAT-1-dependent manner to promote IgG2a production [43] . However, it is still unclear how IFNγ triggers B cells to secrete autoantibody in vivo. We noted that the expression of IFNγ was dramatically elevated both in total spleen and in CD4 + T cells at day 14-post cGVHD induction (Supplementary Figure 2A) . And IFNγ + CD4 + T cells were significantly increased in spleens from mice that received Bm12 splenocytes, compared with the control group (Supplementary Figure 2B) . Notably, the percentage and absolute number of T-bet + CD11c + CD19 + B cells were decreased in IFNGR1-/-mice induced by cGVHD (Supplementary Figure 2C) . Thus, we think that IFNγ might induce the expression of T-bet in B cells leading to their differentiation into CD11c + B cells in cGVHD. Further studies are needed to confirm this hypothesis.
Recently, Rubtsov et al reported that CD11c + B cells were expanded only in a handful of SLE patients [21] .
Others studies have showed that a resembling population of B cells increased in the peripheral blood of RA patients and some autoimmune individuals with common variable immunodeficiency [44] [45] [46] . b. Not all patients were evaluated.
